Associate Professor Ka Fung Peter CHIU - CUHK Research Portal

Professor CHIU Ka Fung Peter

Personal Information

Position and Department

Associate Professor, Department of Surgery

Emailpeterchiu@surgery.cuhk.edu.hk

ORCiD0000-0002-1499-8372

URLhttps://www.surgery.cuhk.edu.hk/profile.asp?alias=peterchiu

CUHK Research Outputs

1 of 4

Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology (2024)

An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy (2024)

A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn? (2024)

A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder Cancer (2024)

Effect of Focal Zone Size on Treatment Outcomes and Renal Injury Following Extracorporeal Shockwave Lithotripsy of Renal Calculi: A Prospective Randomized Study (2024)

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension (2024)

GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer. (2024)

Health-Related Quality of Life Assessment in Prostate Cancer Patient Undergoing Androgen Deprivation Therapy: Real-World Experience in the READT Study (2024)

High-intensity focused ultrasound strategies for treating prostate cancer (2024)

Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study (2024)

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer (2024)

Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial (2024)

Patient preference on once-daily oral versus injectable androgen deprivation therapy for Asian patients with advanced prostate cancer (2024)

Quantitative comparison of the renal pelvic urine and bladder urine to examine modifications of the urine proteome by the lower urinary tract (2024)

Risk prediction of bladder cancer among person with diabetes: A derivation and validation study (2024)

Safety and Efficacy of Immediate Hyperthermic Intravesical Chemotherapy Following Transurethral Resection of Bladder Tumour (I-HIVEC) (2024)

“Seeing Is Believing”: Additive Utility of 68Ga-PSMA-11 PET/CT in Prostate Cancer Diagnosis (2024)

The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study (2024)

Transurethral water vapour thermal therapy for benign prostatic hyperplasia under local anaesthesia alone: initial experience in Chinese patients (2024)

Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real-life experience of ADT in Asia (READT) study (2023)

A prospective evaluation of the effect of finasteride on prostate health index (phi) (2023)

Cross-cultural translation into Chinese and psychometric evaluation of a screening tool for nocturia: the Targeting the individual's Aetiology of Nocturia to Guide Outcomes (TANGO) questionnaire (2023)

Disease-related complications in patients with metastatic hormone-sensitive prostate cancer (2023)

Dissecting the effects of METTL3 on alternative splicing in prostate cancer (2023)

Editorial Comment (2023)

Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs) (2023)

Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking (2023)

Global Variation in Magnetic Resonance Imaging Quality of the Prostate (2023)

Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study (2023)

Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review (2023)

Moving the Needle: Antibiotic Prophylaxis Is No Longer Required in the Era of Transperineal Prostate Biopsy (2023)

MP20-12 PiR-hsa-24683 Is Essential For Prostate Tumor-Propagating Cells And Promote the Development of Castration Resistance (2023)

Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review (2023)

Perineal nerve block versus periprostatic block for patients undergoing transperineal prostate biopsy (APROPOS): a prospective, multicentre, randomised controlled study (2023)

Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement (2023)

Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis (2023)

Prostate Health Index Density Outperforms Prostate-specific Antigen Density in the Diagnosis of Clinically Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging of the Prostate: A Multicenter Evaluation (2023)

Psychological Health of Surgeons in a Time of COVID-19: A Global Survey (2023)

Reply by Authors (2023)

Risk of concomitant prostate cancer in bladder cancer patients going for radical cystectomy (2023)

Robotic augmentation cystoplasty: 1-year outcome of the anterior and posterior approaches (2023)

Robotic radical cystectomy in renal transplant patients: The indocyanine green (ICG) technique (2023)

SARS-CoV-2 infection correlates with male benign prostatic hyperplasia deterioration (2023)

Targeted Microwave Ablation (TMA) of localized prostate cancer guided by MRI-Ultrasound fusion and organ-based tracking: Experience from the first study on clinical efficacy (2023)

The 5 years effects of bariatric surgery on the improvement of lower urinary tract symptoms in morbidly obese male patients (2023)

The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men (2023)

The impact on survival outcomes of different Bacillus Calmette–Guerin strains of non-muscle invasive bladder cancer patients (2023)

Time for change? Feasibility of introducing micromodules into medical student education: a randomised controlled trial (2023)

Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma (2023)

Urinary continence in high-risk prostate cancer after robot-assisted radical prostatectomy (2023)

Research Interest

Prostate cancer
Urology
Prostatic diseases
Benign prostatic hyperplasia

Most Relevant Area

Cancer Biology (Experimental biology)

Share Link

Our policy towards the use of cookies